Glen Stettin Insider Profile
4 Followers
Glen Stettin, Director at MedAvail Holdings, holds ― shares in MedAvail Holdings (Ticker: MDVLQ), holds 1.05K shares in PRA Health Sciences (Ticker: PRAH), holds 45.01K shares in Express Scripts (Ticker: ESRX).
Glen Stettin's Trading History
| PRAHPRA Health Sciences | Jun 03, 2021 | ― | Uninformative Buy | ― | $173.31K | |
| ESRXExpress Scripts | Mar 08, 2018 | ― | Uninformative Buy | ― | $4.16M | |
| MDVLQMedAvail Holdings | ― | Director | ― | ― |
You May Also Like
Glen Stettin insider profile FAQ
What is the percentage of profitable transactions made by Glen Stettin?
The percentage of profitable transactions made by Glen Stettin is 25%.
What is the average return per transaction made by Glen Stettin?
The average return per transaction made by Glen Stettin is 0.80%.
What stocks does Glen Stettin hold?
Glen Stettin holds: MDVLQ, ESRX, PRAH stocks.
What was Glen Stettin's most profitable transaction?
Glen Stettin’s most profitable transaction was an Informative Sell of ESRX stock on February 26, 2015. The return on the trade was 15.60%.
What is Glen Stettin's role in MedAvail Holdings?
Glen Stettin's role in MedAvail Holdings is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
